跳至主要内容
临床试验/NCT06640010
NCT06640010招募中不适用

Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年2月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
30
试验地点
2
主要终点
In vitro measurement of cellular viability in response to chemotherapy

研究概览

简要总结

This study is being done to find out if patient blood samples can be used to perform individualized modeling of cancer therapy-related side effects.

详细描述

PRIMARY OBJECTIVES:

I. Generate induced pluripotent stem cells (iPSC's) from patients receiving cancer treatment.

II. Differentiate patient iPSC's into cardiomyocytes and/or neurons or other cell types that may be relevant to modeling cancer therapy-related adverse effects, such as cardiotoxicity and neurotoxicity.

III. Use patient specific iPSC-derived cells to:

IIIa. Model cancer therapy-related toxicities; IIIb. Better understand the mechanisms of toxicities; IIIc. Determine if patient specific genetic variants are causative of toxicities; IIId. Screen novel protective therapies for cancer therapy-related toxicities.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any patient >= 18 years of age
  • Previously treated, planned or currently receiving any potentially toxic cancer therapy including but not limited to chemotherapy, targeted and immunotherapies

排除标准

  • Inability on the part of the patient to understand the informed consent or be compliant with the protocol

研究组 & 干预措施

Observational

Patients undergo blood sample collection and have their medical records reviewed on study.

干预措施: Non-Interventional Study (Other)

结局指标

主要结局

In vitro measurement of cellular viability in response to chemotherapy

时间窗: Blood drawn at enrollment to obtain sample

Will be compared between cells derived from patients who experienced treatment-induced toxicity to cells derived from patients who received the same cancer therapy without toxicity. Statistical analyses of different endpoints will use Fisher's exact test, one-way ANOVA test followed by all-pairwise-multiple-comparison procedures, or an unpaired, two-tailed Student's t-test with significant differences defined by P \< 0.05.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验